OrbusNeich Medical Group Holdings (FRA:Q8T) OCF Margin %: 16.64% (As of Dec. 2025) — 16% Above Median


FRA:Q8T OrbusNeich Medical Group Holdings Ltd FRA:Q8T
96 GF Score
Price €0.37
GF Value €0.47
! 2 Warning Signs
View Full Analysis

What is OrbusNeich Medical Group Holdings OCF Margin %?

OrbusNeich Medical Group Holdings FRA:Q8T -3.17% 96 OCF Margin % is 16.64% as of Dec. 2025, which is 16% above its 10-year median of 14.32. GuruFocus rates FRA:Q8T with a GF Score™ of 96/100 and a GF Value™ of €0.47. The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, OrbusNeich Medical Group Holdings ranks better than 59.88% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. OrbusNeich Medical Group Holdings's Cash Flow from Operations for the six months ended in Dec. 2025 was €13.8 Mil. OrbusNeich Medical Group Holdings's Revenue for the six months ended in Dec. 2025 was €82.8 Mil. Therefore, OrbusNeich Medical Group Holdings's OCF Margin % for the quarter that ended in Dec. 2025 was 16.64%.

As of today, OrbusNeich Medical Group Holdings's current OCF Yield % is 4.75%.

The historical rank and industry rank for OrbusNeich Medical Group Holdings's OCF Margin % or its related term are showing as below:

FRA:Q8T' s OCF Margin % Range Over the Past 10 Years
Min: 1.65   Med: 14.32   Max: 17.6
Current: 10.78


During the past 7 years, the highest OCF Margin % of OrbusNeich Medical Group Holdings was 17.60%. The lowest was 1.65%. And the median was 14.32%.

FRA:Q8T's OCF Margin % is ranked better than
59.88% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.82 vs FRA:Q8T: 10.78


OrbusNeich Medical Group Holdings OCF Margin % Related Terms


OrbusNeich Medical Group Holdings OCF Margin % Historical Data

* Premium members only.

The historical data trend for OrbusNeich Medical Group Holdings's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrbusNeich Medical Group Holdings OCF Margin % Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial 17.60 17.13 14.97 7.99 10.82

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.73 10.41 5.76 4.08 16.64

FRA:Q8T vs ISRG, BDX, MDLN: OCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrbusNeich Medical Group Holdings OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's OCF Margin % distribution charts can be found below:

* The bar in red indicates where OrbusNeich Medical Group Holdings's OCF Margin % falls into.


FRA:Q8T
96GF Score
OrbusNeich Medical Group Holdings Ltd FRA:Q8T
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OrbusNeich Medical Group Holdings OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

OrbusNeich Medical Group Holdings's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=16.679/154.108
=10.82 %

OrbusNeich Medical Group Holdings's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=13.768/82.756
=16.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 16.64% mean?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a OCF Margin % of 16.64% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on OrbusNeich Medical Group Holdings and its competitors. This is 16% above median its historical median of 14.32. Over the past decade, OrbusNeich Medical Group Holdings' OCF Margin % has ranged from 1.65 to 17.60. According to the industry distribution chart, OrbusNeich Medical Group Holdings ranks #327 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 40.1%.
Is OrbusNeich Medical Group Holdings' OCF Margin % too high?
OrbusNeich Medical Group Holdings' current OCF Margin % of 16.64% is 16% above median its 10-year median of 14.32. Over the past 10 years, this metric has ranged from a low of 1.65 to a high of 17.60. The Medical Devices & Instruments industry median OCF Margin % is 5.82. OrbusNeich Medical Group Holdings' value of 16.64% is 185.9% above this industry median. Based on the distribution chart, OrbusNeich Medical Group Holdings ranks #327 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, OrbusNeich Medical Group Holdings has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does OrbusNeich Medical Group Holdings' OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, OrbusNeich Medical Group Holdings ranks #327 out of 815 companies for OCF Margin %. This puts OrbusNeich Medical Group Holdings in the upper half of its industry. The industry median OCF Margin % is 5.82. OrbusNeich Medical Group Holdings' value of 16.64% is 185.9% above this benchmark. Historically, OrbusNeich Medical Group Holdings' own OCF Margin % has ranged from 1.65 to 17.60 over the past decade. While the company's 10-year median is 14.32 vs. the industry median of 5.82, OrbusNeich Medical Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OrbusNeich Medical Group Holdings's current OCF Margin % of 16.64% is 185.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on OrbusNeich Medical Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrbusNeich Medical Group Holdings's current OCF Margin % is 16.64%, which is 16% above median its own 10-year median of 14.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrbusNeich Medical Group Holdings stock overvalued right now?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a current OCF Margin % of 16.64%. The stock's GF Value™ is €0.47, compared to a current price of €0.37 — trading 22.1% below its estimated fair value. The current OCF Margin % is 16.64%, which is 16% above median its 10-year median of 14.32 and 185.9% above the Medical Devices & Instruments industry median of 5.82. OrbusNeich Medical Group Holdings' overall GF Score™ is 96/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For OrbusNeich Medical Group Holdings (FRA:Q8T), the current OCF Margin % is 16.64% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OrbusNeich Medical Group Holdings (FRA:Q8T) Overvalued in 2026?

Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings stock appears to be undervalued. The current stock price of €0.37 is trading 22.1% below its estimated GF Value™ of €0.47.

Key valuation signals for FRA:Q8T:

  • OCF Margin %: 16.64% (16% above median its 10-year median of 14.32)
  • GF Value™: €0.47 vs. price of €0.37 (22.1% below fair value)
  • GF Score™: 96/100 with 2 warning signs
  • Industry Position: 185.9% above the Medical Devices & Instruments median (#327 of 815)

No single metric tells the full story. See the FRA:Q8T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OrbusNeich Medical Group Holdings Business Description

Other Exchanges 06929:Hong Kong
Address 3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
96GF Score

Get the complete analysis for FRA:Q8T

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.37
Price
€0.47
GF Value